Psp Research Llc Portfolio Stock Holdings
According to the SEC 13F filed on July 9, 2026, Psp Research Llc disclosed 74 stock positions valued at approximately $187.88M as of quarter-end June 30, 2026. The largest holdings include SPDR SERIES TRUST, ISHARES TR, and ROYALTY PHARMA PLC.
- Report Period
- June 30, 2026
- No. of Stocks
- 74
- Portfolio Value
- $187.88M
Holdings by Sector
Psp Research Llc Portfolio Holdings in Q2 2026
| Company | Symbol | Sector | Portfolio % | Shares | Change (Shares) | Change % | Value |
|---|---|---|---|---|---|---|---|
| SPDR SERIES TRUST | XBI | Other | 48.01% | 570,000 | +285,100 | +100.07% | $90,202,500 |
| ISHARES TR | SGOV | Other | 37.51% | 700,000 | - | - | $70,469,000 |
| ROYALTY PHARMA PLC | RPRX | Healthcare | 0.33% | 11,000 | - | - | $616,770 |
| NURIX THERAPEUTICS INC | NRIX | Healthcare | 0.32% | 25,000 | -3,700 | -12.89% | $606,500 |
| INCYTE CORP | INCY | Healthcare | 0.32% | 5,300 | - | - | $600,808 |
| ARGENX SE | ARGX | Healthcare | 0.32% | 641 | - | - | $594,701 |
| DISC MEDICINE INC | IRON | Healthcare | 0.31% | 8,000 | - | - | $585,120 |
| RAPPORT THERAPEUTICS INC | RAPP | Healthcare | 0.31% | 14,000 | - | - | $583,380 |
| ULTRAGENYX PHARMACEUTICAL IN | RARE | Healthcare | 0.30% | 17,000 | -5,100 | -23.08% | $567,630 |
| TREVI THERAPEUTICS INC | TRVI | Healthcare | 0.30% | 30,000 | - | - | $559,500 |
| MONTE ROSA THERAPEUTICS INC | GLUE | Healthcare | 0.30% | 23,000 | -5,000 | -17.86% | $556,600 |
| TG THERAPEUTICS INC | TGTX | Healthcare | 0.29% | 10,000 | -3,000 | -23.08% | $549,400 |
| HALOZYME THERAPEUTICS INC | HALO | Healthcare | 0.29% | 7,000 | -1,026 | -12.78% | $547,890 |
| IONIS PHARMACEUTICALS INC | IONS | Healthcare | 0.29% | 6,800 | - | - | $539,172 |
| PHARVARIS N V | PHVS | Healthcare | 0.28% | 15,000 | -5,000 | -25.00% | $518,700 |
| ARCUTIS BIOTHERAPEUTICS INC | ARQT | Healthcare | 0.27% | 19,700 | - | - | $516,534 |
| AURINIA PHARMACEUTICALS INC | AUPH | Healthcare | 0.27% | 30,000 | - | - | $509,100 |
| NEUROCRINE BIOSCIENCES INC | NBIX | Healthcare | 0.27% | 3,000 | -848 | -22.04% | $505,605 |
| IMMUNOVANT INC | IMVT | Healthcare | 0.27% | 13,000 | -6,200 | -32.29% | $500,890 |
| ACADIA PHARMACEUTICALS INC | ACAD | Healthcare | 0.27% | 19,766 | - | - | $500,080 |
| PTC THERAPEUTICS INC | PTCT | Healthcare | 0.26% | 6,000 | - | - | $489,420 |
| CELLDEX THERAPEUTICS INC NEW | CLDX | Healthcare | 0.26% | 13,000 | - | - | $483,730 |
| IMMUNOCORE HLDGS PLC | IMCR | Healthcare | 0.26% | 15,141 | - | - | $480,727 |
| DEFINIUM THERAPEUTICS INC | DFTX | Healthcare | 0.25% | 10,000 | -24,800 | -71.26% | $470,400 |
| COGENT BIOSCIENCES INC | COGT | Healthcare | 0.25% | 12,000 | - | - | $464,400 |
| KYMERA THERAPEUTICS INC | KYMR | Healthcare | 0.24% | 4,000 | -2,300 | -36.51% | $458,680 |
| DYNE THERAPEUTICS INC | DYN | Healthcare | 0.24% | 20,000 | - | - | $444,200 |
| ALNYLAM PHARMACEUTICALS INC | ALNY | Healthcare | 0.23% | 1,465 | - | - | $441,009 |
| TARSUS PHARMACEUTICALS INC | TARS | Healthcare | 0.23% | 7,000 | - | - | $440,580 |
| SYNDAX PHARMACEUTICALS INC | SNDX | Healthcare | 0.23% | 20,000 | - | - | $437,200 |
Showing 30 of 74 holdings in the latest reporting period.